Related references
Note: Only part of the references are listed.Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study
Ryusuke Yotsueda et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study
Seiji Gotoh et al.
ATHEROSCLEROSIS (2015)
Reflections On The 20th Anniversary Of Taiwan's Single-Payer National Health Insurance System
Tsung-Mei Cheng
HEALTH AFFAIRS (2015)
Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines
Szu-Chun Hung et al.
NEPHROLOGY (2014)
Young stroke patients are at high risk for subsequent end-stage renal disease: a population-based observational study
Peir-Haur Hung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients
Shuo-Ming Ou et al.
KIDNEY INTERNATIONAL (2013)
Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity
Raluca Reitmeir et al.
BRAIN (2011)
A systematic review and meta-analysis of erythropoietin in experimental stroke
Mikael Jerndal et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Taiwan's healthcare report 2010
Willie Sai Ho Chan
EPMA JOURNAL (2010)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
Lynda A. Szczech et al.
KIDNEY INTERNATIONAL (2008)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Emerging biological roles for erythropoietin in the nervous system
M Brines et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models
S Juul
CLINICS IN PERINATOLOGY (2004)
Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa
WA Banks et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
ML Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)